Abvc Biopharma (ABVC) Long-Term Deferred Tax (2017 - 2023)
Abvc Biopharma (ABVC) posted Long-Term Deferred Tax of $34,256 for Q3 2023, down 96.6% from $1.01 million a year earlier and down 3.4% from the prior quarter.
Powered by 
Analysis
Abvc Biopharma (ABVC) Long-Term Deferred Tax (2017 - 2023) Analysis & Trends
At the end of FY2022, Abvc Biopharma's Long-Term Deferred Tax came in at $117,110, down 88.1% from FY2021.
- Annual Long-Term Deferred Tax shows a five-year compound annual growth rate of -27.7% (FY2017 to FY2022).
- In prior years, Abvc Biopharma's Long-Term Deferred Tax was $981,912 in FY2021 (-45.2%), $1.79 million in FY2020 (+22.6%), $1.46 million in FY2019 (+8.3%) and $1.35 million in FY2018 (+126.7%).
- The Q3 2023 figure stands as the lowest quarterly Long-Term Deferred Tax in data going back to Q4 2017.
- On a year-over-year basis, Long-Term Deferred Tax has declined in each of the last eight quarters, with an average decline of 68.8% over the last eight quarters.
- The strongest year-over-year quarter for Long-Term Deferred Tax in the past five years was Q4 2018, with growth of 126.7%; the weakest was Q2 2023, with a decline of 96.7%.
- According to Business Quant data, Long-Term Deferred Tax for the three prior quarters was $35,472 (Q2 2023), $118,191 (Q1 2023) and $117,110 (Q4 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn |
| 10 | Abvc Biopharma | 24.28 Mn | 21.86 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 34,256.00 |
| Jun 30, 2023 | 35,472.00 |
| Mar 31, 2023 | 118,191.00 |
| Dec 31, 2022 | 117,110.00 |
| Sep 30, 2022 | 1.01 Mn |
| Jun 30, 2022 | 1.08 Mn |
| Mar 31, 2022 | 1.04 Mn |
| Dec 31, 2021 | 981,912.00 |
| Sep 30, 2021 | 1.99 Mn |
| Jun 30, 2021 | 1.91 Mn |
| Mar 31, 2021 | 1.82 Mn |
| Dec 31, 2020 | 1.79 Mn |
| Sep 30, 2020 | 1.65 Mn |
| Jun 30, 2020 | 1.58 Mn |
| Mar 31, 2020 | 1.49 Mn |
| Dec 31, 2019 | 1.46 Mn |
| Sep 30, 2019 | 1.38 Mn |
| Jun 30, 2019 | 1.43 Mn |
| Mar 31, 2019 | 1.40 Mn |
| Dec 31, 2018 | 1.35 Mn |
API Access
Abvc Biopharma Long-Term Deferred Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-deferred-tax", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();